Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f071719f4ab-trace').style.display = (document.getElementById('cakeErr67f071719f4ab-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f071719f4ab-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f071719f4ab-code').style.display = (document.getElementById('cakeErr67f071719f4ab-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f071719f4ab-context').style.display = (document.getElementById('cakeErr67f071719f4ab-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f071719f4ab-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f071719f4ab-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 36739,
		&#039;title&#039; =&gt; &#039;Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Indian Express&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;
&lt;br /&gt;
The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;
&lt;br /&gt;
In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Indian Express, 12 June, 2018, http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4684856,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 36739,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),knee implants,Department of Industrial Policy and Promotion (DIPP)&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Indian Express&lt;br /&gt;&lt;br /&gt;&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;&lt;br /&gt;The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;&lt;br /&gt;In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot; title=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 36739,
	&#039;title&#039; =&gt; &#039;Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Indian Express&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;
&lt;br /&gt;
The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;
&lt;br /&gt;
In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Indian Express, 12 June, 2018, http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4684856,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 36739
$metaTitle = &#039;LATEST NEWS UPDATES | Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),knee implants,Department of Industrial Policy and Promotion (DIPP)&#039;
$metaDesc = &#039;
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Indian Express&lt;br /&gt;&lt;br /&gt;&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;&lt;br /&gt;The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;&lt;br /&gt;In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot; title=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Despite no cap &#039;indication&#039;, govt put knee implant under price limit -Deepak Patel | Im4change.org</title>
    <meta name="description" content="
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Despite no cap &#039;indication&#039;, govt put knee implant under price limit -Deepak Patel</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Indian Express<br /><br /><em>The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />New Delhi: </em>After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&rsquo;s Office (PMO) is documented as having &ldquo;indicated&rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />However, on August 16, 2017, the NPPA capped the prices of knee implants in an &ldquo;immediate intervention&rdquo; to &ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &ldquo;there is no question of any assurance being given&rdquo; by its &ldquo;officials&rdquo; and &ldquo;any such statement is baseless&rdquo;.<br /><br />The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.<br /><br />In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &mdash; which she termed as &ldquo;APACMed mission to India&rdquo; &mdash; met Anurag Jain, Joint Secretary, PMO, &ldquo;among others&rdquo; on May 4 or May 5 of 2017. Pratt wrote: &ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.<br /><br />Please <a href="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/" title="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/">click here</a> to read more. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f071719f4ab-trace').style.display = (document.getElementById('cakeErr67f071719f4ab-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f071719f4ab-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f071719f4ab-code').style.display = (document.getElementById('cakeErr67f071719f4ab-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f071719f4ab-context').style.display = (document.getElementById('cakeErr67f071719f4ab-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f071719f4ab-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f071719f4ab-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 36739,
		&#039;title&#039; =&gt; &#039;Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Indian Express&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;
&lt;br /&gt;
The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;
&lt;br /&gt;
In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Indian Express, 12 June, 2018, http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4684856,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 36739,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),knee implants,Department of Industrial Policy and Promotion (DIPP)&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Indian Express&lt;br /&gt;&lt;br /&gt;&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;&lt;br /&gt;The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;&lt;br /&gt;In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot; title=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 36739,
	&#039;title&#039; =&gt; &#039;Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Indian Express&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;
&lt;br /&gt;
The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;
&lt;br /&gt;
In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Indian Express, 12 June, 2018, http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4684856,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 36739
$metaTitle = &#039;LATEST NEWS UPDATES | Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),knee implants,Department of Industrial Policy and Promotion (DIPP)&#039;
$metaDesc = &#039;
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Indian Express&lt;br /&gt;&lt;br /&gt;&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;&lt;br /&gt;The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;&lt;br /&gt;In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot; title=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Despite no cap &#039;indication&#039;, govt put knee implant under price limit -Deepak Patel | Im4change.org</title>
    <meta name="description" content="
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Despite no cap &#039;indication&#039;, govt put knee implant under price limit -Deepak Patel</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Indian Express<br /><br /><em>The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />New Delhi: </em>After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&rsquo;s Office (PMO) is documented as having &ldquo;indicated&rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />However, on August 16, 2017, the NPPA capped the prices of knee implants in an &ldquo;immediate intervention&rdquo; to &ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &ldquo;there is no question of any assurance being given&rdquo; by its &ldquo;officials&rdquo; and &ldquo;any such statement is baseless&rdquo;.<br /><br />The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.<br /><br />In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &mdash; which she termed as &ldquo;APACMed mission to India&rdquo; &mdash; met Anurag Jain, Joint Secretary, PMO, &ldquo;among others&rdquo; on May 4 or May 5 of 2017. Pratt wrote: &ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.<br /><br />Please <a href="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/" title="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/">click here</a> to read more. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f071719f4ab-trace').style.display = (document.getElementById('cakeErr67f071719f4ab-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f071719f4ab-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f071719f4ab-code').style.display = (document.getElementById('cakeErr67f071719f4ab-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f071719f4ab-context').style.display = (document.getElementById('cakeErr67f071719f4ab-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f071719f4ab-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f071719f4ab-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 36739,
		&#039;title&#039; =&gt; &#039;Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Indian Express&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;
&lt;br /&gt;
The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;
&lt;br /&gt;
In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Indian Express, 12 June, 2018, http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4684856,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 36739,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),knee implants,Department of Industrial Policy and Promotion (DIPP)&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Indian Express&lt;br /&gt;&lt;br /&gt;&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;&lt;br /&gt;The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;&lt;br /&gt;In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot; title=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 36739,
	&#039;title&#039; =&gt; &#039;Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Indian Express&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;
&lt;br /&gt;
However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;
&lt;br /&gt;
The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;
&lt;br /&gt;
In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;
&lt;br /&gt;
Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Indian Express, 12 June, 2018, http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4684856,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 36739
$metaTitle = &#039;LATEST NEWS UPDATES | Despite no cap &amp;#039;indication&amp;#039;, govt put knee implant under price limit -Deepak Patel&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),knee implants,Department of Industrial Policy and Promotion (DIPP)&#039;
$metaDesc = &#039;
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Indian Express&lt;br /&gt;&lt;br /&gt;&lt;em&gt;The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;New Delhi: &lt;/em&gt;After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&amp;rsquo;s Office (PMO) is documented as having &amp;ldquo;indicated&amp;rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.&lt;br /&gt;&lt;br /&gt;However, on August 16, 2017, the NPPA capped the prices of knee implants in an &amp;ldquo;immediate intervention&amp;rdquo; to &amp;ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&amp;rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &amp;ldquo;there is no question of any assurance being given&amp;rdquo; by its &amp;ldquo;officials&amp;rdquo; and &amp;ldquo;any such statement is baseless&amp;rdquo;.&lt;br /&gt;&lt;br /&gt;The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&amp;rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.&lt;br /&gt;&lt;br /&gt;In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &amp;mdash; which she termed as &amp;ldquo;APACMed mission to India&amp;rdquo; &amp;mdash; met Anurag Jain, Joint Secretary, PMO, &amp;ldquo;among others&amp;rdquo; on May 4 or May 5 of 2017. Pratt wrote: &amp;ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&amp;rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.&lt;br /&gt;&lt;br /&gt;Please &lt;a href=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot; title=&quot;http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/&quot;&gt;click here&lt;/a&gt; to read more. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Despite no cap &#039;indication&#039;, govt put knee implant under price limit -Deepak Patel | Im4change.org</title>
    <meta name="description" content="
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Despite no cap &#039;indication&#039;, govt put knee implant under price limit -Deepak Patel</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Indian Express<br /><br /><em>The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />New Delhi: </em>After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&rsquo;s Office (PMO) is documented as having &ldquo;indicated&rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />However, on August 16, 2017, the NPPA capped the prices of knee implants in an &ldquo;immediate intervention&rdquo; to &ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &ldquo;there is no question of any assurance being given&rdquo; by its &ldquo;officials&rdquo; and &ldquo;any such statement is baseless&rdquo;.<br /><br />The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.<br /><br />In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &mdash; which she termed as &ldquo;APACMed mission to India&rdquo; &mdash; met Anurag Jain, Joint Secretary, PMO, &ldquo;among others&rdquo; on May 4 or May 5 of 2017. Pratt wrote: &ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.<br /><br />Please <a href="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/" title="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/">click here</a> to read more. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 36739,
		'title' => 'Despite no cap 'indication', govt put knee implant under price limit -Deepak Patel',
		'subheading' => '',
		'description' => '<div align="justify">
-The Indian Express<br />
<br />
<em>The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br />
<br />
New Delhi: </em>After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&rsquo;s Office (PMO) is documented as having &ldquo;indicated&rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br />
<br />
However, on August 16, 2017, the NPPA capped the prices of knee implants in an &ldquo;immediate intervention&rdquo; to &ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &ldquo;there is no question of any assurance being given&rdquo; by its &ldquo;officials&rdquo; and &ldquo;any such statement is baseless&rdquo;.<br />
<br />
The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.<br />
<br />
In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &mdash; which she termed as &ldquo;APACMed mission to India&rdquo; &mdash; met Anurag Jain, Joint Secretary, PMO, &ldquo;among others&rdquo; on May 4 or May 5 of 2017. Pratt wrote: &ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.<br />
<br />
Please <a href="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/">click here</a> to read more. <br />
</div>',
		'credit_writer' => 'The Indian Express, 12 June, 2018, http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4684856,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 36739,
	'metaTitle' => 'LATEST NEWS UPDATES | Despite no cap &#039;indication&#039;, govt put knee implant under price limit -Deepak Patel',
	'metaKeywords' => 'National Pharmaceutical Pricing Authority (NPPA),knee implants,Department of Industrial Policy and Promotion (DIPP)',
	'metaDesc' => '
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February...',
	'disp' => '<div align="justify">-The Indian Express<br /><br /><em>The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />New Delhi: </em>After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&rsquo;s Office (PMO) is documented as having &ldquo;indicated&rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />However, on August 16, 2017, the NPPA capped the prices of knee implants in an &ldquo;immediate intervention&rdquo; to &ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &ldquo;there is no question of any assurance being given&rdquo; by its &ldquo;officials&rdquo; and &ldquo;any such statement is baseless&rdquo;.<br /><br />The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.<br /><br />In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &mdash; which she termed as &ldquo;APACMed mission to India&rdquo; &mdash; met Anurag Jain, Joint Secretary, PMO, &ldquo;among others&rdquo; on May 4 or May 5 of 2017. Pratt wrote: &ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.<br /><br />Please <a href="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/" title="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/">click here</a> to read more. <br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 36739,
	'title' => 'Despite no cap &#039;indication&#039;, govt put knee implant under price limit -Deepak Patel',
	'subheading' => '',
	'description' => '<div align="justify">
-The Indian Express<br />
<br />
<em>The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br />
<br />
New Delhi: </em>After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&rsquo;s Office (PMO) is documented as having &ldquo;indicated&rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br />
<br />
However, on August 16, 2017, the NPPA capped the prices of knee implants in an &ldquo;immediate intervention&rdquo; to &ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &ldquo;there is no question of any assurance being given&rdquo; by its &ldquo;officials&rdquo; and &ldquo;any such statement is baseless&rdquo;.<br />
<br />
The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.<br />
<br />
In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &mdash; which she termed as &ldquo;APACMed mission to India&rdquo; &mdash; met Anurag Jain, Joint Secretary, PMO, &ldquo;among others&rdquo; on May 4 or May 5 of 2017. Pratt wrote: &ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.<br />
<br />
Please <a href="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/">click here</a> to read more. <br />
</div>',
	'credit_writer' => 'The Indian Express, 12 June, 2018, http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'despite-no-cap-039indication039-govt-put-knee-implant-under-price-limit-deepak-patel-4684856',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4684856,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 36739
$metaTitle = 'LATEST NEWS UPDATES | Despite no cap &#039;indication&#039;, govt put knee implant under price limit -Deepak Patel'
$metaKeywords = 'National Pharmaceutical Pricing Authority (NPPA),knee implants,Department of Industrial Policy and Promotion (DIPP)'
$metaDesc = '
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February...'
$disp = '<div align="justify">-The Indian Express<br /><br /><em>The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />New Delhi: </em>After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister&rsquo;s Office (PMO) is documented as having &ldquo;indicated&rdquo; to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.<br /><br />However, on August 16, 2017, the NPPA capped the prices of knee implants in an &ldquo;immediate intervention&rdquo; to &ldquo;check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market&rdquo;. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that &ldquo;there is no question of any assurance being given&rdquo; by its &ldquo;officials&rdquo; and &ldquo;any such statement is baseless&rdquo;.<br /><br />The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India&rsquo;s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.<br /><br />In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials &mdash; which she termed as &ldquo;APACMed mission to India&rdquo; &mdash; met Anurag Jain, Joint Secretary, PMO, &ldquo;among others&rdquo; on May 4 or May 5 of 2017. Pratt wrote: &ldquo;During the meeting, the PMO indicated that the Indian government had no plans to expand price controls&rdquo;. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.<br /><br />Please <a href="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/" title="http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/">click here</a> to read more. <br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Despite no cap 'indication', govt put knee implant under price limit -Deepak Patel

-The Indian Express The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings. New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister’s Office (PMO) is documented as having “indicated” to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings. However, on August 16, 2017, the NPPA capped the prices of knee implants in an “immediate intervention” to “check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market”. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that “there is no question of any assurance being given” by its “officials” and “any such statement is baseless”. The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India’s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US. In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials — which she termed as “APACMed mission to India” — met Anurag Jain, Joint Secretary, PMO, “among others” on May 4 or May 5 of 2017. Pratt wrote: “During the meeting, the PMO indicated that the Indian government had no plans to expand price controls”. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express. Please click here to read more.